Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.
The clinical efficacy of oral pyronaridine was assessed in 22 symptomatic Cameroonian patients infected with Plasmodium ovale or Plasmodium malariae. All patients were cured on or before day 4. In vitro drug assays confirmed the sensitivity of P. ovale and P. malariae isolates to chloroquine and pyr...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1997
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9333075/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.10.2317 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|